NSC |
Compound |
Enrichment |
Correlation |
NSC 632831 |
Null |
0.0107933723273943 |
-0.11488745 |
NSC 639512 |
Cyclopentanone, 2-[(4-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride |
0.0107933723273943 |
-0.093287324 |
NSC 643813 |
3'-O-(Carboxymethyl)-(Z)-Combretastatin 4-A, Na salt, hydrate [1:1:2] |
0.0107933723273943 |
-0.17095475 |
NSC 649091 |
Null |
0.0107933723273943 |
-0.027068591 |
NSC 658142 |
2-(1-(4-(2-Pyridyl)piperazino))naphthazarin |
0.0107933723273943 |
0.11807689 |
NSC 665103 |
Benzene, 1,1'-[(3,4,4-trichloro-2-nitro- 1,3-butadienylidene)bis(thio)]bis- (9CI) |
0.0107933723273943 |
-0.056502604 |
NSC 668814 |
1-Oxa-4,7,10,13,16-pentaazacyclononadecane, cyclic peptide derivative |
0.0107933723273943 |
0.077361838 |
NSC 670785 |
Null |
0.0107933723273943 |
0.18766178 |
NSC 684836 |
Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- |
0.0107933723273943 |
0.17574403 |
NSC 688500 |
Null |
0.0107933723273943 |
-0.17950366 |